Clinical Trials Logo

Otitis Externa clinical trials

View clinical trials related to Otitis Externa.

Filter by:

NCT ID: NCT01447017 Completed - Clinical trials for Acute Otitis Externa

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

Start date: November 2011
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate safety and tolerability of DPK-060 2% ear drops compared to placebo for DPK-060 ear drops in patients with acute external otitis. The secondary objectives are to evaluate clinical cure and microbiological growth following treatment with DPK-060 2% ear drops compared to placebo for DPK-060 ear drops.

NCT ID: NCT01359098 Completed - Clinical trials for Otorhinolaryngologic Diseases

Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa

Ciprodexa Foam
Start date: July 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the Safety and Efficacy of Ciprodexa Foam (0.3% Ciprofloxacin, 0.1% Dexamethasone Otic Foam), used once-a-day for 7 days for the treatment of Acute Diffuse Otitis Externa, compared to Ciprodex otic suspension used twice daily for 7 days.

NCT ID: NCT01157819 Completed - Clinical trials for Otorhinolaryngologic Diseases

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis

Once-a-day
Start date: July 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the Safety and Efficacy of Foam Otic Cipro (0.3% Ciprofloxacin Otic Foam), used once-daily for 7 days for the treatment of Acute Diffuse Otitis Externa, compared to commercial ear drops used twice daily for 7 days.

NCT ID: NCT00980876 Completed - Otitis Externa Clinical Trials

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The objective of this study is to compare the efficacy and safety profiles of the test product containing 2 mg/mL ciprofloxacin hydrochloride associated with 10 mg/mL of hydrocortisone with the reference product Cipro HC®, in patients with acute otitis externa.

NCT ID: NCT00961675 Completed - Clinical trials for Acute Otitis Externa

FST-201 in the Treatment of Acute Otitis Externa

Start date: August 31, 2009
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy of FST-201 compared to Ciprodex in the treatment of acute otitis externa. This study will be conducted at one site, the Lyndon B. Johnson (LBJ) Tropical Medical Center, Department of Otolaryngology, in Pago Pago, American Samoa.

NCT ID: NCT00872209 Completed - Clinical trials for Otorhinolaryngologic Diseases

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa

Start date: May 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the Safety and Efficacy of Foam Otic Cipro, a novel medication developed to treat Acute Diffuse Otitis Externa of bacterial origin. The working hypothesis is that Foam Otic Cipro is as effective as registered ear drops.

NCT ID: NCT00750633 Completed - Clinical trials for Acute Otitis Externa

A Phase III Study of an Otic Formulation in Acute Otitis Externa

Start date: June 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if an otic formulation is safe and effective for the treatment of acute otitis externa (AOE).